Protuoso Biosciences co-founders Willie Xiang (left) and Tim Lu
May 26, 2026 09:17 AM EDT
FinancingStartups
Exclusive: Protuoso gets $9.5M to build the next hub-and-spoke antibody developer
Kyle LaHucik
Variations on the hub-and-spoke model have blossomed in the drug development industry over the past few years — and a new antibody hub is entering the fray.
Protuoso Biosciences co-founders Willie Xiang (left) and Tim Lu
May 26, 2026 09:17 AM EDT
FinancingStartups
Exclusive: Protuoso gets $9.5M to build the next hub-and-spoke antibody developer
Kyle LaHucik

California startup Protuoso raises $9.5m for “mix-and-match” drug platform - Pharmaceutical Technology

Biohub unveils AI world model for drug discovery, enhancing protein design

Pfizer, Innovent strike $10B cancer drug deal

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

Mark Zuckerberg's philanthropic venture unveils AI world model for drug discovery - The Economic Times